MedPath

Effects of acotiamide on esophageal motility and EGJ distensibility for gastroesophageal reflux disease.

Not Applicable
Conditions
GERD
Registration Number
JPRN-UMIN000032438
Lead Sponsor
Shimane University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Post operation of esophagus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in esophageal motor function and distensibility of the esophagogastric junction after administration of acotiamide 300 mg / day for 3 days and after the last dose 2 hours.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath